Managing the multiple symptoms of benign prostatic hyperplasia.
Warren Alpert Medical School, Brown University, Providence, RI, USA.
Martin
M
Miner
D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use; D058668:Adrenergic alpha-1 Receptor Antagonists / Q000627:therapeutic use; D006801:Humans; D008019:Life Style; D008297:Male; D008403:Mass Screening; D008487:Medical History Taking; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000175:diagnosis / Q000628:therapy; D057832:Watchful Waiting
D058891:5-alpha Reductase Inhibitors; D058668:Adrenergic alpha-1 Receptor Antagonists; D058986:Phosphodiesterase 5 Inhibitors